Distinguished Professor Ian Reid - Principal Investigator
Dr Anne Horne - Co-Investigator
Angela Stewart - Study Coordinator
This study is a prospective, randomised, placebo-controlled, double-blind trial to be carried out over a period of 6 years. Two thousand osteopenic postmenopausal women consenting to participate and meeting the inclusion/exclusion criteria have been randomly assigned to receive infusions of either zoledronic acid 5 mg or normal saline every 18 months. The primary end-point is osteoporotic fracture which will be monitored at visits. Bone density and vertebral x-rays will be assessed at baseline, 3 years and 6 years.
Recruitment is complete for this study.
Please feel free to contact the researchers if you have any questions about this study.
The main paper describing this study has now been published by the New England Journal of Medicine. Please click here to read the paper.
Bone and Joint Research Group
University of Auckland
Auckland Hospital
Private Bag 92024
Auckland
Dr Anne Horne
Phone: +64 9 923 9787
Email: a.horne@auckland.ac.nz
Leanne Purvis - Appointments
Phone: +64 9 923 8607
Email: leanne.purvis@auckland.ac.nz
Angela Stewart
Phone: +64 9 923 9788
Email: angela.stewart@auckland.ac.nz